The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19

FK Yoshimoto - The protein journal, 2020 - Springer
The devastating effects of the recent global pandemic (termed COVID-19 for “coronavirus
disease 2019”) caused by the severe acute respiratory syndrome coronavirus-2 (SARS CoV …

Neutrophil extracellular traps (NETs) and damage‐associated molecular patterns (DAMPs): two potential targets for COVID‐19 treatment

S Cicco, G Cicco, V Racanelli… - Mediators of …, 2020 - Wiley Online Library
COVID‐19 is a pandemic disease caused by the new coronavirus SARS‐CoV‐2 that mostly
affects the respiratory system. The consequent inflammation is not able to clear viruses. The …

Inoculating against fake news about COVID-19

S van Der Linden, J Roozenbeek… - Frontiers in …, 2020 - frontiersin.org
The outbreak of the SARS-CoV-2 novel coronavirus (COVID-19) has been accompanied by
a large amount of misleading and false information about the virus, especially on social …

A randomized clinical trial of the efficacy and safety of interferon β-1a in treatment of severe COVID-19

E Davoudi-Monfared, H Rahmani… - Antimicrobial agents …, 2020 - Am Soc Microbiol
To the best of our knowledge, there is no published study on the use of interferon β-1a (IFN
β-1a) in the treatment of severe COVID-19. In this randomized clinical trial, the efficacy and …

COVID‐19 and liver disease—what we know on 1st May 2020

I Garrido, R Liberal, G Macedo - Alimentary pharmacology & …, 2020 - Wiley Online Library
Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the
causative pathogen of coronavirus disease 2019 (COVID‐19), became a global threat to …

Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis

Z Kashour, M Riaz, MA Garbati… - Journal of …, 2021 - academic.oup.com
Objectives Clinical studies of chloroquine (CQ) and hydroxychloroquine (HCQ) in COVID-19
disease reported conflicting results. We sought to systematically evaluate the effect of CQ …

Possibility of magnesium supplementation for supportive treatment in patients with COVID-19

CF Tang, H Ding, RQ Jiao, XX Wu, LD Kong - European journal of …, 2020 - Elsevier
Magnesium as an enzymatic activator is essential for various physiological functions such as
cell cycle, metabolic regulation, muscle contraction, and vasomotor tone. A growing body of …

SARS-CoV-2: Targeted managements and vaccine development

M Bakhiet, S Taurin - Cytokine & growth factor reviews, 2021 - Elsevier
Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) results in
diverse outcomes. The symptoms appear to be more severe in males older than 65 and …

Hydroxychloroquine in COVID-19: potential mechanism of action against SARS-CoV-2

S Satarker, T Ahuja, M Banerjee, VB E, S Dogra… - Current pharmacology …, 2020 - Springer
Abstract Purpose of Review The rapid spread of virus, severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has turned out to be a global emergency. Symptoms of this …

[HTML][HTML] A Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients.

ATMM Chowdhury, M Shahbaz, MR Karim, J Islam… - 2020 - europepmc.org
Background: The worldwide COVID-19 pandemic was caused by a newly discovered
Coronavirus. The treatment methods for COVID-19 are emerging and rapidly evolving …